{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:30:02Z","timestamp":1790519402021,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The CERP study was partially supported by Grunenthal-Italia."},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC 2015 IG-17727"],"award-info":[{"award-number":["AIRC 2015 IG-17727"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC 2013 IG-14249"],"award-info":[{"award-number":["AIRC 2013 IG-14249"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC 2014 IG-15314"],"award-info":[{"award-number":["AIRC 2014 IG-15314"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nausea and vomiting are often associated with opioid analgesia in cancer patients; however, only a subset of patients develop such side effects. Here, we tested the hypothesis that the occurrence of nausea and vomiting is modulated by the genetic background of the patients. Whole exome sequencing of DNA pools from patients with either low (n\u2009=\u2009937) or high (n\u2009=\u2009557) nausea and vomiting intensity, recruited in the European Pharmacogenetic Opioid Study, revealed a preliminary association of 53 polymorphisms. PCR-based genotyping of 45 of these polymorphisms in the individual patients of the same series confirmed the association for six SNPs in <jats:italic>AIM1L, CLCC1, MUC16, PDE3A, POM121L2<\/jats:italic>, and <jats:italic>ZNF165<\/jats:italic> genes. Genotyping of the same 45 polymorphisms in 264 patients of the Italian CERP study, also treated with opioids for cancer pain, instead confirmed the association for two SNPs in <jats:italic>ZNF568<\/jats:italic> and <jats:italic>PDE3A<\/jats:italic> genes. Only one SNP, rs12305038 in <jats:italic>PDE3A<\/jats:italic>, was confirmed in both series, although with opposite effects of the minor allele on the investigated phenotype. Overall, our findings suggest that genetic factors are indeed associated with nausea and vomiting in opioid-treated cancer patients, but the role of individual polymorphisms may be weak.<\/jats:p>","DOI":"10.1038\/s41598-019-57358-y","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T11:03:05Z","timestamp":1579258985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2015-4317","authenticated-orcid":false,"given":"Francesca","family":"Colombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pintarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Galvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Noci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Corli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Skorpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Klepstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein","family":"Kaasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4198-9620","authenticated-orcid":false,"given":"Rocco","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pirola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6058-515X","authenticated-orcid":false,"given":"Carlo","family":"Gambacorti-Passerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto Tommaso","family":"Caraceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"57358_CR1","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni, A. et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 13, e58\u201368 (2012).","journal-title":"Lancet Oncol."},{"key":"57358_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","volume":"34","author":"SC Teunissen","year":"2007","unstructured":"Teunissen, S. C. et al. Symptom prevalence in patients with incurable cancer: a systematic review. J. Pain Symptom Manage. 34, 94\u2013104 (2007).","journal-title":"J. Pain Symptom Manage."},{"key":"57358_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1191\/0269216305pm1054oa","volume":"19","author":"P Klepstad","year":"2005","unstructured":"Klepstad, P. et al. Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research. Network. Palliat. Med. 19, 477\u2013484 (2005).","journal-title":"Network. Palliat. Med."},{"key":"57358_CR4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jpain.2015.05.006","volume":"16","author":"AW Oosten","year":"2015","unstructured":"Oosten, A. W., Oldenmenger, W. H., Mathijssen, R. H. & van der Rijt, C. C. A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures. J. Pain 16, 935\u2013946 (2015).","journal-title":"J. Pain"},{"key":"57358_CR5","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.ejca.2011.04.014","volume":"47","author":"EA Laugsand","year":"2011","unstructured":"Laugsand, E. A. et al. Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids. Eur. J. Cancer 47, 1682\u20131691 (2011).","journal-title":"Eur. J. Cancer"},{"key":"57358_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00228-011-1093-5","volume":"68","author":"TN Andreassen","year":"2012","unstructured":"Andreassen, T. N. et al. Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study. Eur. J. Clin. Pharmacol. 68, 55\u201364 (2012).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"57358_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.tig.2009.12.008","volume":"26","author":"A Galvan","year":"2010","unstructured":"Galvan, A., Ioannidis, J. P. & Dragani, T. A. Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet. 26, 132\u2013141 (2010).","journal-title":"Trends Genet."},{"key":"57358_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","volume":"6","author":"NJ Roberts","year":"2016","unstructured":"Roberts, N. J. et al. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer. Discov. 6, 166\u2013175 (2016).","journal-title":"Cancer. Discov."},{"key":"57358_CR9","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1158\/1078-0432.CCR-13-2755","volume":"20","author":"SK Low","year":"2014","unstructured":"Low, S. K., Takahashi, A., Mushiroda, T. & Kubo, M. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics. Clin. Cancer Res. 20, 2541\u20132552 (2014).","journal-title":"Clin. Cancer Res."},{"key":"57358_CR10","doi-asserted-by":"crossref","unstructured":"Tizaoui, K. Multiple sclerosis genetics: Results from meta-analyses of candidate-gene association studies. Cytokine (2017).","DOI":"10.1016\/j.cyto.2017.10.024"},{"key":"57358_CR11","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1200\/JCO.2010.32.6884","volume":"29","author":"GP Kurita","year":"2011","unstructured":"Kurita, G. P. et al. Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study. J. Clin. Oncol. 29, 1297\u20131303 (2011).","journal-title":"J. Clin. Oncol."},{"key":"57358_CR12","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/annonc\/mdw097","volume":"27","author":"O Corli","year":"2016","unstructured":"Corli, O. et al. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV \u2018real life\u2019 trial on the variability of response to opioids. Ann. Oncol. 27, 1107\u20131115 (2016).","journal-title":"Ann. Oncol."},{"key":"57358_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1601-183X.2010.00608.x","volume":"9","author":"NL Saccone","year":"2010","unstructured":"Saccone, N. L. et al. Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans. Genes Brain Behav. 9, 741\u2013750 (2010).","journal-title":"Genes Brain Behav."},{"key":"57358_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep33256","volume":"6","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. Investigation of rare and low-frequency variants using high-throughput sequencing with pooled DNA samples. Sci. Rep. 6, 33256 (2016).","journal-title":"Sci. Rep."},{"key":"57358_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep29085","volume":"6","author":"T Kaartokallio","year":"2016","unstructured":"Kaartokallio, T. et al. Exome sequencing in pooled DNA samples to identify maternal pre-eclampsia risk variants. Sci. Rep. 6, 29085 (2016).","journal-title":"Sci. Rep."},{"key":"57358_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00030.2010","volume":"91","author":"SH Francis","year":"2011","unstructured":"Francis, S. H., Blount, M. A. & Corbin, J. D. Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions. Physiol. Rev. 91, 651\u2013690 (2011).","journal-title":"Physiol. Rev."},{"key":"57358_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0092-8674(03)00077-1","volume":"112","author":"H Amrein","year":"2003","unstructured":"Amrein, H. & Bray, S. Bitter-sweet solution in taste transduction. Cell 112, 283\u2013284 (2003).","journal-title":"Cell"},{"key":"57358_CR18","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/ng.3405","volume":"47","author":"N Kato","year":"2015","unstructured":"Kato, N. et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat. Genet. 47, 1282\u20131293 (2015).","journal-title":"Nat. Genet."},{"key":"57358_CR19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/tpj.2014.79","volume":"15","author":"S Sadhasivam","year":"2015","unstructured":"Sadhasivam, S. et al. Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects. Pharmacogenomics J. 15, 436\u2013442 (2015).","journal-title":"Pharmacogenomics J."},{"key":"57358_CR20","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s00221-014-3987-9","volume":"232","author":"S Sugino","year":"2014","unstructured":"Sugino, S. et al. Association of mu-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting. Exp. Brain Res. 232, 2627\u20132635 (2014).","journal-title":"Exp. Brain Res."},{"key":"57358_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2217\/pgs-2017-0002","volume":"18","author":"R Balyan","year":"2017","unstructured":"Balyan, R. et al. OCT1 genetic variants are associated with postoperative morphine-related adverse effects in children. Pharmacogenomics 18, 621\u2013629 (2017).","journal-title":"Pharmacogenomics"},{"key":"57358_CR22","first-page":"131","volume":"18","author":"ZY Ren","year":"2015","unstructured":"Ren, Z. Y. et al. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. Pain Physician. 18, 131\u2013152 (2015).","journal-title":"Pain Physician."},{"key":"57358_CR23","unstructured":"World Health Organization. WHO. Cancer pain relief. 2nd ed. World Health Organization, Geneva (1996)."},{"key":"57358_CR24","unstructured":"Knudsen, A. K. et al. Which variables are associated with pain intensity and treatment response in advanced cancer patients? - Implications for a future classification system for cancer pain. Eur. J. Pain (2010)."},{"key":"57358_CR25","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1158\/1078-0432.CCR-10-3028","volume":"17","author":"A Galvan","year":"2011","unstructured":"Galvan, A. et al. Multiple Loci modulate opioid therapy response for cancer pain. Clin. Cancer Res. 17, 4581\u20134587 (2011).","journal-title":"Clin. Cancer Res."},{"key":"57358_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N. K. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 85, 365\u2013376 (1993).","journal-title":"J. Natl. Cancer Inst."},{"key":"57358_CR27","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/S0959-8049(00)00186-6","volume":"36","author":"K Bjordal","year":"2000","unstructured":"Bjordal, K. et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur. J. Cancer 36, 1796\u20131807 (2000).","journal-title":"Eur. J. Cancer"},{"key":"57358_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/oxfordjournals.annonc.a058263","volume":"3","author":"M Tamburini","year":"1992","unstructured":"Tamburini, M. et al. A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. Ann. Oncol. 3, 565\u2013570 (1992).","journal-title":"Ann. Oncol."},{"key":"57358_CR29","unstructured":"Fayers, P. M. et al. The EORTC QLQ-C30 Scoring Manual (3rd Edition). European Organisation for Research and Treatment of Cancer, Brussels (2001)."},{"key":"57358_CR30","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"57358_CR31","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"57358_CR32","doi-asserted-by":"publisher","first-page":"e74825","DOI":"10.1371\/journal.pone.0074825","volume":"8","author":"R Piazza","year":"2013","unstructured":"Piazza, R. et al. CEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data. PLoS One 8, e74825 (2013).","journal-title":"PLoS One"},{"key":"57358_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ng.2495","volume":"45","author":"R Piazza","year":"2013","unstructured":"Piazza, R. et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat. Genet. 45, 18\u201324 (2013).","journal-title":"Nat. Genet."},{"key":"57358_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57358-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:49:28Z","timestamp":1670305768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57358-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["57358"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-57358-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"27 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"542"}}